Featured Firms
Presented by BigVoodoo
Dublin-based generic drug maker Actavis is buying Forest Laboratories in a $25 billion cash-and-stock deal that increases Actavis' access to specialty drugs. Latham is advising longtime client Actavis on the deal, while Forest has turned to Wachtell. Other firms working on the deal include Skadden, which is counseling Actavis on antitrust issues, as well as Fried Frank and Simpson Thacher, which are representing financial advisers Greenhill & Co. and J.P. Morgan, respectively.
February 18, 2014 at 06:54 PM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS